Devices/Safety Alert·openFDA/device

COBALT¿ XT DR MRI SURESCAN¿ (MEDTRONIC EUROPE SARL) — Injury

MediumPublished May 31, 2026· AI-analyzed Jun 8, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

An injury event was reported involving the Cobalt XT DR MRI SureScan device manufactured by Medtronic Europe SARL.

Who it affects

This affects Medtronic Europe SARL, healthcare providers utilizing MRI-compatible implantable pulse generators, and personnel responsible for device safety monitoring and reporting.

Why it matters

The classification of the event as an injury regarding an MRI-compatible implantable device necessitates careful review of performance data. While specific failure modes are not detailed in the source, such reports typically lead to internal investigations to determine if the event was related to device malfunction, off-label use, or procedural complications.

Practical takeaway

Regulatory and quality teams should ensure post-market surveillance protocols for these specific models are active and that any incoming adverse event reports are triaged for potential signal detection or trend analysis.

FDA source material

Event type: Injury. Device: COBALT¿ XT DR MRI SURESCAN¿ by MEDTRONIC EUROPE SARL.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.